Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held N/A

Laurie Stelzer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2022
SELL
Other acquisition or disposition
-
37,208 Reduced 100.0%
0 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
21,462 Added 37.11%
36,366 Common Stock
Mar 16 2021
SELL
Payment of exercise price or tax liability
$331,492 $76.1 p/Share
4,356 Reduced 22.62%
14,904 Common Stock
Mar 16 2021
BUY
Exercise of conversion of derivative security
-
12,600 Added 39.55%
19,260 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
6,660 Added 50.0%
6,660 Common Stock

Also insider at

PMVP
PMV Pharmaceuticals, Inc. Healthcare
SURF
Surface Oncology, Inc. Healthcare
MRTX
Mirati Therapeutics, Inc. Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
LS

Laurie Stelzer

EVP & Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on ARNA

Follow ARENA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARNA shares.

Notify only if

Insider Trading

Get notified when an Arena Pharmaceuticals Inc insider buys or sells ARNA shares.

Notify only if

News

Receive news related to ARENA PHARMACEUTICALS INC

Track Activities on ARNA